Its time to make a new entry in IBIO. Very oversold on every indicators. The price has a strong long term support around 0.35. It may rebound before test it, around 0.4. If price recovers and stays above 0.5, founding there a strong support, may initiate a recovery with 0.9 as price target.
After FDA approval ETRM had unexpected correction due to challenges and associated costs to develop and market the new device. If price recovers soon and stays above 1.45, we may see a upside trend with 1.9 target following the development of the potential H&S pattern.
Tons of shares were moved last weeks, mostly at prices far above actual pps. Not only wild speculation justifies those volumes and not all buyers "evacuated" their positions even with the following massive short attack, similar but not great in magnitude. Based on expected demand for antiviral treatment to stop ebola outbreaks, mainly in west african countries,...
